Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis E Almaguer-Mederos

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 2021
Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 PatientsLuis E Almaguer-Mederos, Ilbedis Pérez-Ávila, Raúl Aguilera-Rodríguez, et al.
The Lancet. Neurology|March 25, 2014
Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal studyLuis Velázquez-Pérez, Roberto Rodríguez-Labrada, Nalia Canales-Ochoa, et al.
Frontiers in Neurology|June 30, 2017
Spinocerebellar Ataxia Type 2 Is Associated with the Extracellular Loss of Superoxide Dismutase but Not Catalase ActivityDennis Almaguer-Gotay, Luis E Almaguer-Mederos, Raul Aguilera-Rodríguez, et al.
Journal of the Neurological Sciences|September 24, 2013
Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testingYaimeé Vázquez-Mojena, Leonides Laguna-Salvia, José M Laffita-Mesa, et al.
Journal of the Neurological Sciences|January 15, 2010
Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up studyLuis Velázquez-Perez, Roberto Rodríguez-Labrada, Nalia Canales-Ochoa, et al.
Journal of Community Genetics|April 21, 2015
SCA2 predictive testing in Cuba: challenging concepts and protocol evolutionTania Cruz-Mariño, Yaimeé Vázquez-Mojena, Luis Velázquez-Pérez, et al.
Archives of Medical Research|September 20, 2017
Buccal Cell Micronucleus Frequency Is Significantly Elevated in Patients with Spinocerebellar Ataxia Type 2Dany A Cuello-Almarales, Luis E Almaguer-Mederos, Yaimé Vázquez-Mojena, et al.
Journal of the Neurological Sciences|December 27, 2016
Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2Luis E Almaguer-Mederos, Dennis Almaguer-Gotay, Raúl Aguilera-Rodríguez, et al.
Oxidative Medicine and Cellular Longevity|March 10, 2021
Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2Almaguer-Gotay Dennis, Luis E Almaguer-Mederos, Rodríguez-Aguilera Raúl, et al.
Cerebellum (London, England)|May 23, 2020
Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 PatientsLuis E Almaguer-Mederos, Raúl Aguilera-Rodríguez, Dennis Almaguer-Gotay, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 2021
Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 PatientsLuis E Almaguer-Mederos, Ilbedis Pérez-Ávila, Raúl Aguilera-Rodríguez, et al.
The Lancet. Neurology|March 25, 2014
Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal studyLuis Velázquez-Pérez, Roberto Rodríguez-Labrada, Nalia Canales-Ochoa, et al.
Frontiers in Neurology|June 30, 2017
Spinocerebellar Ataxia Type 2 Is Associated with the Extracellular Loss of Superoxide Dismutase but Not Catalase ActivityDennis Almaguer-Gotay, Luis E Almaguer-Mederos, Raul Aguilera-Rodríguez, et al.
Journal of the Neurological Sciences|September 24, 2013
Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testingYaimeé Vázquez-Mojena, Leonides Laguna-Salvia, José M Laffita-Mesa, et al.
Journal of the Neurological Sciences|January 15, 2010
Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up studyLuis Velázquez-Perez, Roberto Rodríguez-Labrada, Nalia Canales-Ochoa, et al.
Journal of Community Genetics|April 21, 2015
SCA2 predictive testing in Cuba: challenging concepts and protocol evolutionTania Cruz-Mariño, Yaimeé Vázquez-Mojena, Luis Velázquez-Pérez, et al.
Archives of Medical Research|September 20, 2017
Buccal Cell Micronucleus Frequency Is Significantly Elevated in Patients with Spinocerebellar Ataxia Type 2Dany A Cuello-Almarales, Luis E Almaguer-Mederos, Yaimé Vázquez-Mojena, et al.
Journal of the Neurological Sciences|December 27, 2016
Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2Luis E Almaguer-Mederos, Dennis Almaguer-Gotay, Raúl Aguilera-Rodríguez, et al.
Oxidative Medicine and Cellular Longevity|March 10, 2021
Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2Almaguer-Gotay Dennis, Luis E Almaguer-Mederos, Rodríguez-Aguilera Raúl, et al.
Cerebellum (London, England)|May 23, 2020
Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 PatientsLuis E Almaguer-Mederos, Raúl Aguilera-Rodríguez, Dennis Almaguer-Gotay, et al.
Pageof 2